LOYOLA UNIVERSITY HEALTH SYSTEMASPIRE Study
ASPIRE Study
ASPIRE Study
204291
Number of Participants
350
Eligibility
Ventricular tachycardia, drug refractory (including beta-blockers), ICD implanted, history of MI
Purpose
The purpose of this study is to determine if early ablation and medical therapy is more effective than medical therapy alone in treating ventricular tachycardia.
Treatment
Participants will be randomly assigned to receive ablation and medical therapy, or medical therapy alone for the treatment of ventricular arrhythmias.
Principal Investigator
David J. Wilber
M.D., FAHA, FACC
Cardiology
George M. Eisenberg Professor of Cardiovascular Sciences
Enrollment
(708) 216-2646
